科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/08/08 | 3,810 | 3,840 | 3,770 | 3,780 | -35 | -0.9% | 49,500 |
| 2022/08/05 | 3,740 | 3,820 | 3,740 | 3,815 | +75 | +2% | 93,900 |
| 2022/08/04 | 3,780 | 3,785 | 3,715 | 3,740 | +30 | +0.8% | 78,400 |
| 2022/08/03 | 3,775 | 3,780 | 3,680 | 3,710 | -65 | -1.7% | 195,900 |
| 2022/08/02 | 3,870 | 3,870 | 3,760 | 3,775 | -120 | -3.1% | 93,500 |
| 2022/08/01 | 3,875 | 3,895 | 3,850 | 3,895 | +15 | +0.4% | 66,400 |
| 2022/07/29 | 3,965 | 3,965 | 3,860 | 3,880 | -95 | -2.4% | 88,000 |
| 2022/07/28 | 3,980 | 3,985 | 3,930 | 3,975 | -10 | -0.3% | 51,900 |
| 2022/07/27 | 4,020 | 4,040 | 3,970 | 3,985 | -35 | -0.9% | 50,800 |
| 2022/07/26 | 4,020 | 4,055 | 3,995 | 4,020 | ±0 | ±0% | 60,200 |
| 2022/07/25 | 4,050 | 4,060 | 4,005 | 4,020 | -25 | -0.6% | 49,200 |
| 2022/07/22 | 4,050 | 4,075 | 4,035 | 4,045 | +10 | +0.2% | 74,200 |
| 2022/07/21 | 3,935 | 4,040 | 3,930 | 4,035 | +30 | +0.7% | 81,500 |
| 2022/07/20 | 4,020 | 4,020 | 3,965 | 4,005 | +75 | +1.9% | 120,000 |
| 2022/07/19 | 3,945 | 3,945 | 3,880 | 3,930 | -15 | -0.4% | 60,800 |
| 2022/07/15 | 3,995 | 4,010 | 3,940 | 3,945 | -35 | -0.9% | 62,400 |
| 2022/07/14 | 3,950 | 3,990 | 3,950 | 3,980 | +30 | +0.8% | 49,700 |
| 2022/07/13 | 3,950 | 3,985 | 3,950 | 3,950 | -5 | -0.1% | 40,200 |
| 2022/07/12 | 3,985 | 3,990 | 3,935 | 3,955 | -40 | -1% | 67,800 |
| 2022/07/11 | 3,930 | 3,995 | 3,930 | 3,995 | +100 | +2.6% | 92,500 |
| 2022/07/08 | 3,900 | 3,955 | 3,850 | 3,895 | -10 | -0.3% | 121,800 |
| 2022/07/07 | 3,940 | 3,940 | 3,870 | 3,905 | ±0 | ±0% | 77,600 |
| 2022/07/06 | 3,855 | 3,920 | 3,855 | 3,905 | +40 | +1% | 79,100 |
| 2022/07/05 | 3,880 | 3,880 | 3,835 | 3,865 | ±0 | ±0% | 72,500 |
| 2022/07/04 | 3,845 | 3,880 | 3,845 | 3,865 | +55 | +1.4% | 60,800 |
| 2022/07/01 | 3,830 | 3,880 | 3,805 | 3,810 | -5 | -0.1% | 78,200 |
| 2022/06/30 | 3,845 | 3,880 | 3,805 | 3,815 | +15 | +0.4% | 133,800 |
| 2022/06/29 | 3,750 | 3,805 | 3,750 | 3,800 | +45 | +1.2% | 129,600 |
| 2022/06/28 | 3,730 | 3,780 | 3,710 | 3,755 | ±0 | ±0% | 93,900 |
| 2022/06/27 | 3,780 | 3,780 | 3,730 | 3,755 | -10 | -0.3% | 42,900 |
| 2022/06/24 | 3,765 | 3,770 | 3,740 | 3,765 | +10 | +0.3% | 41,000 |
| 2022/06/23 | 3,730 | 3,775 | 3,730 | 3,755 | +20 | +0.5% | 62,400 |
| 2022/06/22 | 3,710 | 3,745 | 3,700 | 3,735 | +55 | +1.5% | 55,400 |
| 2022/06/21 | 3,685 | 3,715 | 3,660 | 3,680 | +5 | +0.1% | 55,000 |
| 2022/06/20 | 3,755 | 3,755 | 3,670 | 3,675 | -35 | -0.9% | 68,200 |
| 2022/06/17 | 3,700 | 3,725 | 3,665 | 3,710 | -25 | -0.7% | 92,800 |
| 2022/06/16 | 3,715 | 3,765 | 3,715 | 3,735 | +20 | +0.5% | 51,500 |
| 2022/06/15 | 3,740 | 3,760 | 3,715 | 3,715 | -10 | -0.3% | 56,200 |
| 2022/06/14 | 3,740 | 3,760 | 3,720 | 3,725 | -35 | -0.9% | 60,500 |
| 2022/06/13 | 3,715 | 3,780 | 3,715 | 3,760 | +35 | +0.9% | 69,200 |
| 2022/06/10 | 3,740 | 3,770 | 3,725 | 3,725 | -35 | -0.9% | 67,100 |
| 2022/06/09 | 3,755 | 3,810 | 3,750 | 3,760 | +15 | +0.4% | 60,500 |
| 2022/06/08 | 3,720 | 3,775 | 3,720 | 3,745 | +45 | +1.2% | 63,200 |
| 2022/06/07 | 3,685 | 3,715 | 3,680 | 3,700 | +20 | +0.5% | 46,800 |
| 2022/06/06 | 3,670 | 3,710 | 3,670 | 3,680 | ±0 | ±0% | 58,200 |
| 2022/06/03 | 3,685 | 3,705 | 3,675 | 3,680 | +25 | +0.7% | 66,600 |
| 2022/06/02 | 3,680 | 3,680 | 3,635 | 3,655 | -25 | -0.7% | 43,100 |
| 2022/06/01 | 3,625 | 3,705 | 3,625 | 3,680 | +80 | +2.2% | 70,700 |
| 2022/05/31 | 3,655 | 3,690 | 3,600 | 3,600 | -40 | -1.1% | 98,900 |
| 2022/05/30 | 3,615 | 3,670 | 3,600 | 3,640 | +60 | +1.7% | 128,400 |
701～
750
件表示中 / 3723件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 386,000円 | -6.4% | -71.8% | 4.92% | 43.11倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 378,000円 | +21.7% | +999.9% | 0.00% | 15.84倍 | 5.24倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.47倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 東和薬品 | 299,900円 | +7.9% | -3.3% | 2.67% | 8.34倍 | 0.86倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 203,900円 | +3.1% | -6.5% | 2.35% | 9.46倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
